Published in Drug Saf on May 01, 1994
A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoides. Br J Dermatol (2014) 1.44
Epidemiology of atypical melanocytic naevi: an analytical study in a Mediterranean population. Eur J Cancer Prev (1997) 1.43
Control of the differentiation state and function of human epidermal Langerhans cells by cytokines in vitro. J Eur Acad Dermatol Venereol (2001) 1.41
Early apoptosis plays an important role in the healing mechanism of cutaneous basal cell carcinomas after photodynamic therapy. Br J Dermatol (2003) 1.39
Improvement of malignant/benign ratio in excised melanocytic lesions in the 'dermoscopy era': a retrospective study 1997-2001. Br J Dermatol (2004) 1.38
Dermoscopy and early diagnosis of melanoma: the light and the dark. Arch Dermatol (2001) 1.33
Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma. J Clin Oncol (1994) 1.16
Oral keratinocyte immune responses in HIV-associated candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1997) 1.08
Non-invasive analysis of melanoma thickness by means of dermoscopy: a retrospective study. Melanoma Res (2001) 0.95
Immunoglobulin heavy chain variable region family expression in primary cutaneous follicle centre cell lymphomas. Br J Dermatol (2001) 0.94
Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C. J Chemother (2005) 0.93
Malignant melanoma in Italy: risks associated with common and clinically atypical melanocytic nevi. J Am Acad Dermatol (1995) 0.92
Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. Eur J Cancer (1997) 0.92
A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease. Am J Clin Pathol (1999) 0.92
Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases. Cancer (1991) 0.92
Melanoma detection rate and concordance between self-skin examination and clinical evaluation in patients attending a pigmented lesion clinic in Italy. Br J Dermatol (2002) 0.91
Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev (1995) 0.91
Adhesion molecule profile and malignancy of melanocytic lesions. Melanoma Res (1993) 0.91
Self-detected cutaneous melanomas in Italian patients. Clin Exp Dermatol (2004) 0.90
Diagnostic and referral accuracy of family doctors in melanoma screening: effect of a short formal training. Eur J Cancer Prev (2005) 0.90
Immunocompetent cells in oral candidiasis of HIV-infected patients: an immunohistochemical and electron microscopical study. Oral Dis (1997) 0.86
Skin-associated lymphoid tissue (SALT)-related B-cell lymphoma (primary cutaneous B-cell lymphoma). A concept and a clinicopathologic entity. Arch Dermatol (1993) 0.86
Ultrastructural findings in bullous pemphigoid. J Cutan Pathol (1975) 0.85
Topical corticosteroids. Which drug and when? Drugs (1992) 0.84
In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expression. Melanoma Res (1997) 0.84
The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin. Clin Exp Dermatol (2003) 0.84
Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. J Am Acad Dermatol (1999) 0.84
Dendritic cells in cutaneous lupus erythematosus: a clue to the pathogenesis of lesions. Histopathology (1994) 0.84
Hepatitis C virus: a common triggering factor for both nodular vasculitis and Sjögren's syndrome? Br J Dermatol (2000) 0.82
Dermatophyte infection in ichthyosis vulgaris. Mycoses (1993) 0.82
Immunohistochemical evidence of skin immune system involvement in vulvar lichen sclerosus et atrophicus. Dermatologica (1991) 0.82
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary. G Ital Dermatol Venereol (2012) 0.82
Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop. G Ital Dermatol Venereol (2013) 0.81
Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study. Contact Dermatitis (2001) 0.81
CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regression. Blood (1999) 0.81
Indolent cutaneous B-cell lymphoma: diagnosis and treatment 2012. G Ital Dermatol Venereol (2012) 0.81
Primary cutaneous follicular centre-cell lymphoma--a lymphoproliferative disease with favourable prognosis. Clin Exp Dermatol (1989) 0.80
Dendritic cells in the dermal infiltrate of Sézary syndrome. Histopathology (1986) 0.80
Macrophage-T lymphocyte relationships in man's contact allergic reactions. Br J Dermatol (1983) 0.79
Inhibited differentiation of Langerhans cells in the rat epidermis upon systemic treatment with cyclosporin A. Histol Histopathol (2001) 0.79
Langerhans cells and mycosis fungoides--a critical overview of their pathogenic role in the disease. Clin Exp Dermatol (1990) 0.79
Macrophage--T-lymphocyte interaction in lichen planus. An electron microscopic and immunocytochemical study. Arch Dermatol Res (1983) 0.79
Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas. J Invest Dermatol (2004) 0.79
Non-lymphoid accessory cells in the cutaneous infiltrate of B cell lymphomas. An immunohistochemical and ultrastructural study. Br J Dermatol (1988) 0.78
Melanocytic naevi: clinical features and correlation with the phenotype in healthy young males in Italy. Br J Dermatol (1991) 0.78
Langerhans cells are not damaged in contact allergic reactions in humans. Am J Dermatopathol (1986) 0.78
Extracorporeal photochemotherapy induces a significant increase in CD36+ circulating monocytes in patients with mycosis fungoides. Dermatology (1997) 0.78
Ki67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions. J Invest Dermatol (1990) 0.78
Cell surface marker studies in a patient with cutaneous multilobated T-cell lymphoma. Br J Dermatol (1985) 0.78
Dermatoscopy in the diagnosis of pigmented skin lesions: a new semiology for the dermatologist. J Eur Acad Dermatol Venereol (2000) 0.78
Primary cutaneous follicular center cell lymphoma: clinical and histological aspects. Curr Probl Dermatol (1990) 0.77
Familial and sporadic melanoma: different clinical and histopathological features in the Italian population - a multicentre epidemiological study - by GIPMe (Italian Multidisciplinary Group on Melanoma). J Eur Acad Dermatol Venereol (2011) 0.77
On the subject of distinction between erythropoietic porphyrias and hepatic porphyrias: re-exmination of 90 years case report. Panminerva Med (1967) 0.77
Preoperative assessment of melanoma thickness by ABCD score of dermatoscopy. J Am Acad Dermatol (2000) 0.77
Skin melanoma in Italy: a population-based study on survival and prognostic factors. Eur J Cancer (1998) 0.77
Mycosis fungoides: disease evolution of the "lion queen" revisited. G Ital Dermatol Venereol (2012) 0.76
Spatial association of melanocytic naevus and melanoma. Melanoma Res (1992) 0.76
Incidence of cutaneous melanoma in the centre of Italy: anatomic site distribution, histologic types and thickness of tumour invasion in a registry-based study. Melanoma Res (1994) 0.76
Immunophenotypic analysis of normal human dendritic cells isolated from epidermis and dermis. Int J Dermatol (1998) 0.76
Morphology and membrane antigens of nonlymphoid accessory cells in oral hairy leukoplakia. Hum Pathol (1990) 0.76
Pre-operative diagnosis of pigmented skin lesions: in vivo dermoscopy performs better than dermoscopy on photographic images. J Eur Acad Dermatol Venereol (2002) 0.76
Cyclosporin-A affects the organization of cytoskeleton of normal human keratinocytes in culture. Histol Histopathol (1996) 0.76
Dendritic cells in T- and B-cell proliferation in the skin. Dermatol Clin (1994) 0.76
Nerve growth factor receptor expression on dendritic reticulum cells in cutaneous B-cell lymphoma. Hum Pathol (1992) 0.75
Primary cutaneous CD30+ T-cell lymphomas: hypothesis for a highly distinctive clinicobiological behaviour. J Eur Acad Dermatol Venereol (2001) 0.75
Combination treatment in CTCL: the current role of bexarotene. G Ital Dermatol Venereol (2012) 0.75
Classic and immunodeficiency-associated Kaposi's sarcoma. Clinical, histologic, and immunologic correlations. Arch Pathol Lab Med (1988) 0.75
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients. Dermatology (2015) 0.75
Cutaneous B-cell lymphomas: facts and open issues. J Eur Acad Dermatol Venereol (2004) 0.75
Conversion from calcineurin inhibitors to everolimus with low-dose cyclosporine in renal transplant recipients with squamous cell carcinoma of the skin. Transplant Proc (2012) 0.75
Multiple marker studies on a malignant fibrous histiocytoma with primary cutaneous localization. Tumori (1988) 0.75
Topical cyclosporine in the treatment of vulvar lichen sclerosus: clinical, histologic, and immunohistochemical findings. Arch Dermatol (1992) 0.75
[Masked cutaneous leishmaniasis]. G Ital Dermatol Venereol (1988) 0.75
[Parapsoriasis en plaques and mycosis fungoides: an unclear relationship]. G Ital Dermatol Venereol (1989) 0.75
Topical cyclosporine in the treatment of vulvar lichen sclerosus: clinical, histologic, and immunohistochemical findings. Arch Dermatol (1992) 0.75
A peculiar case of linear IgA bullous dermatosis. Arch Dermatol (1991) 0.75
[Cutaneous involvement in myelo-monocytic leukemia]. G Ital Dermatol Venereol (1986) 0.75
Phase II study of interferon alpha-2a and dacarbazine in advanced melanoma. Am J Clin Oncol (1990) 0.75
Clobetasol propionate 0.05% cream in the treatment of vulvar lichen sclerosus: effect on the immunohistological profile. Br J Dermatol (1992) 0.75
In situ immunologic characterization of cutaneous involvement in Hodgkin's disease. Cancer (1989) 0.75
Langerhans cells and epidermal microenvironment. Am J Dermatopathol (1989) 0.75
[Significance and possible role of reactive T-cell infiltrate in primary B-cell lymphoma of the skin]. G Ital Dermatol Venereol (1990) 0.75
["Specific" skin lesions in chronic lymphatic leukemia]. G Ital Dermatol Venereol (1990) 0.75
Interdigitating reticulum cells in the dermal infiltrate of mycosis fungoides. An ultrastructural and immunohistochemical study. Virchows Arch A Pathol Anat Histopathol (1988) 0.75
Bilateral chondroma of the auricle. J Dermatol Surg Oncol (1988) 0.75
[Sclerosing epithelial hamartoma: a typical picture, a name that causes debate]. G Ital Dermatol Venereol (1987) 0.75
Unsolved problems in nosography of cutaneous porphyrias. Dermatol Int (1967) 0.75
Antigenic phenotype of radial growth phase melanomas with or without a vertical growth phase portion. Tumori (1988) 0.75
[Sezaryś cells: in vitro immunologic activity and effect of thymostimulin]. G Ital Dermatol Venereol (1987) 0.75
[Cultured epidermis in the treatment of leg ulcer: "edge effect" and correlation with keratinocyte proliferation index]. G Ital Dermatol Venereol (1990) 0.75